Anchorage Capital Group’s Ginkgo Bioworks DNA Stock Holding History

Anchorage Capital Group’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.7M	Hold	1,746,363	–	–	2.45%	3
2025 Q4	$14.5M	Hold	1,746,363	–	–	16.39%	2
2025 Q3	$25.5M	Hold	1,746,363	–	–	21.69%	2
2025 Q2	$19.6M	Hold	1,746,363	–	–	7.59%	4
2025 Q1	$9.95M	Hold	1,746,363	–	–	3.98%	5
2024 Q4	$17.1M	Hold	1,746,363	–	–	6.03%	4
2024 Q3	$14.2M	Sell	1,746,363 -2	-0%	-$20	3.73%	4
2024 Q2	$23.4M	Hold	1,746,365	–	–	7.21%	4
2024 Q1	$81M	Hold	1,746,365	–	–	21.09%	3
2023 Q4	$118M	Hold	1,746,365	–	–	14.05%	3
2023 Q3	$126M	Hold	1,746,365	–	–	19.23%	3
2023 Q2	$130M	Hold	1,746,365	–	–	19.44%	3
2023 Q1	$92.9M	Hold	1,746,365	–	–	14.36%	3
2022 Q4	$118M	Buy	1,746,365 +17,406	+1%	+$1.6M	15.14%	3
2022 Q3	$216M	Hold	1,728,959	–	–	19.25%	2
2022 Q2	$165M	Hold	1,728,959	–	–	16.46%	2
2022 Q1	$279M	Hold	1,728,959	–	–	18.94%	2
2021 Q4	$575M	Buy	1,728,959 +50,175	+3%	+$23.8M	30.39%	1
2021 Q3	$778M	Buy	+1,678,784	New	+$817M	49.35%	2

Other funds holding DNA

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Legal & General Group

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return